Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Saved in:
| Title: | Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling. |
|---|---|
| Authors: | Norita R; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan., Suzuki Y; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan., Furutani Y; Micro-Signaling Regulation Technology Unit, RIKEN Center for Life Science Technologies, Saitama, Japan., Takahashi K; Laboratory of Oncology, Graduate School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Yoshimatsu Y; Department of Cellular Physiological Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Podyma-Inoue KA; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Watabe T; Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Sato Y; Department of Vascular Biology, Institute of Development Aging, and Cancer, Tohoku University, Sendai, Japan. |
| Source: | Cancer science [Cancer Sci] 2017 Mar; Vol. 108 (3), pp. 419-426. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
